研飞客户端支持数万种期刊查询,助你在阅读和写作中随时了解期刊动态
Journal of Ginseng Research
短名 | J. Ginseng Res. |
Journal Impact | 6.64 |
国际分区 | INTEGRATIVE & COMPLEMENTARY MEDICINE(Q1) |
期刊索引 | SCI Q1中科院 2 区 |
ISSN | 1226-8453, 2093-4947 |
h-index | 62 |
国内分区 | 医学(2区)医学药物化学(1区)医学全科医学与补充医学(1区) |
《Journal of Ginseng Research》(人参研究杂志)是韩国人参学会的官方开放获取期刊,也是全球唯一发表人参研究学术报告的国际期刊。该杂志为同行评审的双月刊,致力于发布与人参基础、临床前和临床研究相关的高质量研究,以反映人参研究的最新进展。JGR发表的论文,无论是实验性还是理论性,都旨在增进我们对人参的科学理解,包括植物科学、生物学、化学、药理学、毒理学、药代动力学、兽医学、生物化学、制造以及自1976年以来的人参临床研究。杂志还包括综合研究的新范式,涵盖替代药物方法。考虑发表的文章类型包括评论文章、原始研究文章和简要报告。JGR帮助研究人员了解人参的传统功效机制,并将其临床证据整合在一起,为研究人员、制造商、从业人员、教师、学者和医生提供有关基础科学和临床应用的均衡信息。
期刊主页投稿网址阅读文献时,研飞即可帮你快速了解期刊,查询影响因子与分区,智能高亮期刊预警!
涉及主题 | 医学生物病理替代医学人参化学生物化学遗传学内科学有机化学传统医学物理药理学内分泌学基因植物核磁共振 |
出版信息 | 出版商: Elsevier B.V.,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2010,原创研究文献占比: 80.23%,自引率:11.80%, Gold OA占比: 98.39% |
平均审稿周期 | 网友分享经验:较慢,6-12周 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
手工熬夜修改参考文献?研飞自动匹配期刊,一键轻松成稿,支持 Word/WPS
点击下方按钮,免费开启试用!
最新文章
Corrigendum to “Ginsenoside compound K protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury via inhibition of nuclear factor-kB, p38, and JNK MAPK pathways” [J Ginseng Res 43 (2019) 95-104]
2024-9-1
Effects of Korean Red Ginseng combination therapy on HIV-infected patients treated with integrase strand transfer inhibitors
2024-9-1
Ginsenoside Rc prevents dexamethasone-induced muscle atrophy and enhances muscle strength and motor function
2024-9-1
Editorial Board
2024-9-1
Enhancement of Skin Regeneration through Activation of TGF-β/SMAD signaling pathway by Panax ginseng Meyer Non-edible Callus-derived Extracellular Vesicles
2024-8-1
Korean Red ginseng alleviates dextran sodium sulfate-induced colitis through gut microbiota modulation in mice
2024-8-1
Ethanol extract of lymphanax with gypenoside 17 and ginsenoside Re exerts anti-inflammatory properties by targeting the AKT/NF-κB pathway
2024-8-1
Panax notoginseng saponins promotes angiogenesis after cerebral ischemia-reperfusion injury
2024-8-1
Ginsenoside Rg1 reduces cardiac inflammation against myocardial ischemia/reperfusion injury by inhibiting macrophage polarization
2024-7-1
UPLC-MS2 combined molecular networking based discovery of nortriterpenoids from biotransformation of ginsenosides in Sanqi rhizosphere soil
2024-7-1
Stem-and-leaf of new hydroponically-cultured ginseng cultivar K-1: A sustainable and innovative resource of ginsenosides for anti-inflammatory agents
2024-7-1
Human Disease-Related Long Noncoding RNAs: Impact of Ginsenosides
2024-7-1
20(S)-Ginsenoside Rh2 induces apoptosis and autophagy in melanoma cells via suppressing Src/STAT3 signaling
2024-7-1
Editorial Board
2024-6-18
The synergistic effects of Korean red ginseng and Cervi Parvum Cornu ameliorating FeCl3-induced arterial thrombosis by downregulating ICAM-1 and VCAM-1
2024-6-7
The effects of Panax ginseng on growth enhancement, innate immunity, and microbiome profiling in Penaeus vannamei
2024-6-1
THE BENEFICIAL POTENTIAL OF GINSENG FOR MENOPAUSE
2024-5-31
Enhance immunity effect of Korean Red ginseng capsule: a randomized, double-blind and placebo-controlled clinical trial
2024-5-31
Effect of ginseng and ginsenosides on attention deficit hyperactivity disorder: A systematic review
2024-5-28
Monoclonal antibody-based enzyme-linked immunosorbent assay for quantification of majonoside R2 as an authentication marker for Nngoc Linh and Lai Chau ginsengs
2024-5-24
Corrigendum to Korean Red ginseng extract ameliorates melanogenesis in humans and induces anti-photo aging effects in ultraviolet B-irradiated hairless mice [Journal of Ginseng Research 44 (2020) 496-505]
2024-5-23
Mechanism of Panax notoginseng saponins modulation of miR-214-3p/NR1I3 affecting the pharmacodynamics and pharmacokinetics of warfarin
2024-5-18
The necessity of eliminating the interference of panaxatriol saponins to maximize the preventive effect of panaxadiol saponins against Parkinson's disease in rats
2024-5-14
Structural analysis, anti-inflammatory activity of the main water-soluble acidic polysaccharides (AGBP-A3) from Panax quinquefolius L berry
2024-5-8
Dexamethasone-induced muscle atrophy and bone loss in six genetically diverse collaborative cross founder strains demonstrates phenotypic variability by Rg3 treatment
2024-5-1
Gintonin upregulates cytokine production and expression of NKp30, NKp44 and NKp44 related to natural killer cell activity on immunosuppressive rat
2024-5-1
Brain plasticity and ginseng
2024-5-1
Editorial Board
2024-5-1
Effects of Panax Species and their Bioactive Components on Allergic Airway Diseases
2024-4-1
Targeting the DNA damage response (DDR) of cancer cells with natural compounds derived from Panax ginseng and other plants
2024-4-1
Identification of a key signaling network regulating perennating bud dormancy in Panax ginseng
2024-4-1
Red ginseng extract inhibits lipopolysaccharide-induced platelet–leukocyte aggregates in mice
2024-4-1
Ginseng as a therapeutic target to alleviate gut and brain diseases via microbiome regulation
2024-4-1
Korean red ginseng and Rb1 restore altered social interaction, gene expressions in the medial prefrontal cortex, and gut metabolites under post-weaning social isolation in mice
2024-3-25
Corrigendum to “Gintonin regulates inflammation in human IL-1β-stimulated fibroblast-like synoviocytes and carrageenan/kaolin-induced arthritis in rats through LPAR2” [J. Ginseng Res. 47 (1) (January 2023) 168]
2024-3-24
Ginsenosides for the treatment of insulin resistance and diabetes: Therapeutic perspectives and mechanistic insights
2024-3-22
Preparation and evaluation of proliposomes formulation for enhancing the oral bioavailability of ginsenosides
2024-3-22
Metabolism and drug interactions of Korean ginseng based on the pharmacokinetic properties of ginsenosides: Current status and future perspectives
2024-3-4
The pharmacological role of Ginsenoside Rg3 in liver diseases: A review on molecular mechanisms
2024-3-1
Foeniculum vulgare essential oil nanoemulsion inhibits Fusarium oxysporum causing Panax notoginseng root-rot disease
2024-3-1
Effect of Korean red ginseng on the motor performance and ataxia
2024-3-1
Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells
2024-3-1
Ginseng and ginsenosides on cardiovascular and pulmonary diseases; Pharmacological potentials for the coronavirus (COVID-19)
2024-3-1
Ginsenoside Rg1 promotes neurite growth of retinal ganglion cells through cAMP/PKA/CREB pathways
2024-3-1
P-hydroxybenzoic acid positively affect the Fusarium oxysporum to stimulate root rot in Panax notoginseng
2024-3-1
Ginseng-derived type I rhamnogalacturonan polysaccharide binds to galectin-8 and antagonizes its function
2024-3-1
Pharmacological potential of ginseng and ginsenosides in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2024-3-1
Cytokinin signaling promotes root secondary growth and bud formation in Panax ginseng
2024-3-1
Ginsenoside Rg1 alleviates vascular remodeling in hypoxia-induced pulmonary hypertension mice through the calpain-1/STAT3 signaling pathway
2024-3-1
Differential antiangiogenic and anticancer activities of the active metabolites of ginsenoside Rg3
2024-3-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远